Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial.
about
Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways.Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients.
P2860
Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Proteins of the VEGFR and EGFR ...... : results of the FOGT-4 trial.
@en
type
label
Proteins of the VEGFR and EGFR ...... : results of the FOGT-4 trial.
@en
prefLabel
Proteins of the VEGFR and EGFR ...... : results of the FOGT-4 trial.
@en
P2093
P2860
P1476
Proteins of the VEGFR and EGFR ...... r: results of the FOGT-4 trial
@en
P2093
Andrea Formentini
Annett Maderer
Arno Schad
Arthur Hoffman
Jens Martin Kittner
Johannes Wilhelm Rey
Karl-Heinrich Link
Mario Trautmann
Marko Kornmann
Markus Moehler
P2860
P2888
P356
10.1186/S13046-014-0083-8
P50
P577
2014-10-02T00:00:00Z
P6179
1008172508